| Nocodazole | Experimental | ABCC3 | 8714 |
upregulated | Nocodazole results in increased expression of ABCC3 mRNA | 17q21.33 | |
| Nocodazole | Experimental | HAMP | 57817 |
downregulated | Nocodazole results in decreased expression of HAMP mRNA | 19q13.12 | |
| Nonivamide | Approved | ATF3 | 467 |
upregulated | [nonivamide binds to and results in increased activity of TRPV1 protein] which results in increased expression of ATF3 mRNA | 1q32.3 | |
| Nonivamide | Approved | ATF3 | 467 |
upregulated | nonivamide results in increased expression of ATF3 mRNA | 1q32.3 | |
| Nonivamide | Approved | CCND1 | 595 |
downregulated | nonivamide results in decreased expression of CCND1 mRNA | 11q13.3 | |
| Nonivamide | Approved | CCNG2 | 901 |
upregulated | [nonivamide binds to and results in increased activity of TRPV1 protein] which results in increased expression of CCNG2 mRNA | 4q21.1 | |
| Nonivamide | Approved | CCNG2 | 901 |
upregulated | nonivamide results in increased expression of CCNG2 mRNA | 4q21.1 | |
| Nonivamide | Approved | DDIT3 | 1649 |
upregulated | [nonivamide binds to and results in increased activity of TRPV1 protein] which results in increased expression of DDIT3 mRNA | 12q13.3 | |
| Nonivamide | Approved | DDIT3 | 1649 |
upregulated | nonivamide results in increased expression of DDIT3 mRNA | 12q13.3 | |
| Nonivamide | Approved | GADD45A | 1647 |
upregulated | [nonivamide binds to and results in increased activity of TRPV1 protein] which results in increased expression of GADD45A mRNA | 1p31.3 | |
| Nonivamide | Approved | GADD45A | 1647 |
upregulated | nonivamide results in increased expression of GADD45A mRNA | 1p31.3 | |
| Nonivamide | Approved | HSPA5 | 3309 |
upregulated | [nonivamide binds to and results in increased activity of TRPV1 protein] which results in increased expression of HSPA5 mRNA | 9q33.3 | |
| Nonivamide | Approved | HSPA5 | 3309 |
upregulated | nonivamide results in increased expression of HSPA5 mRNA | 9q33.3 | |
| Norepinephrine | Approved Investigational | F3 | 2152 |
upregulated | Norepinephrine results in increased expression of F3 mRNA | 1p21.3 | |
| Norepinephrine | Approved Investigational | HMOX1 | 3162 |
upregulated | Norepinephrine results in increased expression of HMOX1 mRNA | 22q12.3 | |
| Norepinephrine | Approved Investigational | ICAM1 | 3383 |
upregulated | Norepinephrine results in increased expression of ICAM1 mRNA | 19p13.2 | |
| Norepinephrine | Approved Investigational | MMP2 | 4313 |
upregulated | Norepinephrine results in increased expression of MMP2 mRNA | 16q12.2 | |
| Norepinephrine | Approved Investigational | MMP9 | 4318 |
upregulated | Norepinephrine results in increased expression of MMP9 mRNA | 20q13.12 | |
| Norepinephrine | Approved Investigational | S100A8 | 6279 |
upregulated | Norepinephrine results in increased expression of S100A8 mRNA | 1q21.3 | |
| Norepinephrine | Approved Investigational | S100A9 | 6280 |
upregulated | Norepinephrine results in increased expression of S100A9 mRNA | 1q21.3 | |
| Norepinephrine | Approved Investigational | S100B | 6285 |
upregulated | Norepinephrine results in increased expression of S100B mRNA | 21q22.3 | |
| Norepinephrine | Approved Investigational | SOD2 | 6648 |
upregulated | Norepinephrine results in increased expression of SOD2 mRNA | 6q25.3 | |
| Norethisterone | Approved Investigational | ABCB1 | 5243 |
upregulated | Norethindrone results in increased expression of ABCB1 mRNA | 7q21.12 | |
| Norethisterone | Approved Investigational | VEGFA | 7422 |
upregulated | Norethindrone results in increased expression of VEGFA mRNA | 6p21.1 | |
| Norethisterone | Approved Investigational | VEGFA | 7422 |
upregulated | Norethindrone results in increased expression of VEGFA mRNA alternative form | 6p21.1 | |